MediWound (MDWD) Capital Leases (2019 - 2020)

MediWound (MDWD) recorded quarterly Capital Leases of $1.9 million in Q1 2020, down 5.03% quarter-over-quarter from $2.0 million in Q4 2019, and down 6.75% on a YoY basis from $2.0 million in Q2 2019.

MediWound (MDWD) Capital Leases (2019 - 2020) Analysis & Trends

MediWound's Capital Leases history runs 2 years deep, the most recent figure standing at $1.9 million for Q1 2020.

  • In Q1 2020, Capital Leases fell 6.75% year-over-year to $1.9 million; the TTM figure through Mar 2020 stood at $1.9 million (down 6.75% YoY), while the FY2019 annual figure was $2.0 million, changed N/A from the prior year.
  • Capital Leases was $1.9 million for Q1 2020 at MediWound, down from $2.0 million in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $2.0 million in Q1 2019 to a low of $1.9 million in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 MediWound 3.70 Mn 3.70 Mn 278,000.00

Historic Data

Download Data
DateValue
Mar 31, 2020 1.91 Mn
Dec 31, 2019 2.01 Mn
Jun 30, 2019 2.02 Mn
Mar 31, 2019 2.04 Mn